Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Novavax Inc (NASDAQ:NVAX)

1.06
Delayed Data
As of 3:59pm ET
 +0.04 / +3.92%
Today’s Change
0.73
Today|||52-Week Range
1.78
-15.87%
Year-to-Date
No recent news for Novavax Inc.

Today’s Trading

Previous close1.02
Today’s open1.01
Day’s range0.98 - 1.08
Volume7,492,735
Average volume (3 months)5,888,291
Market cap$300.1M
Dividend yield--
Data as of 3:59pm ET, 10/19/2017

Growth & Valuation

Earnings growth (last year)-71.67%
Earnings growth (this year)+39.92%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)-57.65%
P/E ratioNM
Price/Sales22.22
Price/Book--

Competitors

 Today’s
change
Today’s
% change
AGENAgenus Inc-0.24-5.10%
EDGEEdge Therapeutics In...+0.06+0.59%
BTXBioTime Inc+0.04+1.49%
RIGLRigel Pharmaceutical...-0.05-1.24%
Data as of 4:10pm ET, 10/19/2017

Financials

Next reporting dateNovember 8, 2017
EPS forecast (this quarter)-$0.16
Annual revenue (last year)$15.4M
Annual profit (last year)-$280.0M
Net profit margin-1,823.53%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Stanley C. Erck
Senior VP-
Global Manufacturing Operations
Timothy Jon Hahn
Corporate headquarters
Gaithersburg, Maryland

Forecasts